Skip to main content

Advertisement

SpringerLink
Log in

Expression of semaphorin class 3 is higher in the proliferative phase on the human endometrium

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

The semaphorins are related to angiogenesis and cell proliferation depending on the tissue. The purpose of this study was to assess gene expression of class 3 semaphorin (SEMA3A-F) and protein expression of semaphorin 3A (SEMA3A) within human endometrium throughout the menstrual cycle.

Methods

Gene expression of SEMA3A-F was analyzed by real-time PCR (qRT-PCR) and protein expression of SEMA3A was analyzed by ELISA in endometrial biopsies in the proliferative and secretory phase of the menstrual cycle.

Results

Gene expression of SEMA3A, SEMA3C, SEMA3D, and SEMA3E was statistically significant decreased in secretory compared to proliferative phase endometrium (p < 0.05). Accordingly, SEMA3A protein expression in the secretory phase was lower than protein expression in proliferative phase endometrium (p ≤ 0.05).

Conclusion

SEMA3A, 3C, 3D, and 3E are possibly related to cell proliferation in the endometrium, being more expressed in the proliferative phase of the cycle. This finding may stimulate studies of class 3 semaphorins as a possible target for treatment of endometrial pathologies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yazdani U, Terman JR (2006) The semaphorins. Genome Biol 7(3):211

    Article  PubMed  PubMed Central  Google Scholar 

  2. Movassagh H, Khadem F, Gounni AS (2018) Semaphorins and their roles in airway biology: potential as therapeutic targets. Am J Respir Cell Mol Biol 58(1):21–27

    Article  PubMed  Google Scholar 

  3. Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O (2016) The role of the semaphorins in cancer. Cell Adhes Migr 10(6):652–674

    Article  CAS  Google Scholar 

  4. Mann F, Chauvet S, Rougon G (2007) Semaphorins in development and adult brain: implication for neurological diseases. Prog Neurobiol 82(2):57–79

    Article  CAS  PubMed  Google Scholar 

  5. Tamagnone L, Comoglio PM (2004) To move or not to move? Semaphorin signalling in cell migration. EMBO Rep 5(4):356–361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chauvet S, Cohen S, Yoshida Y, Fekrane L, Livet J, Gayet O et al (2007) Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56(5):807–822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Falk J, Bechara A, Fiore R, Nawabi H, Zhou H, Hoyo-Becerra C et al (2005) Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. Neuron 48(1):63–75

    Article  PubMed  Google Scholar 

  8. Ben-Zvi A, Ben-Gigi L, Klein H, Behar O (2007) Modulation of semaphorin3A activity by p75 neurotrophin receptor influences peripheral axon patterning. J Neurosci 27(47):13000–13011

    Article  CAS  PubMed  Google Scholar 

  9. Suto F, Ito K, Uemura M, Shimizu M, Shinkawa Y, Sanbo M et al (2005) Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci 25(14):3628–3637

    Article  CAS  PubMed  Google Scholar 

  10. Yaron A, Huang PH, Cheng HJ, Tessier-Lavigne M (2005) Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 semaphorins. Neuron 45(4):513–523

    Article  CAS  PubMed  Google Scholar 

  11. Germeyer A, Hamilton AE, Laughlin LS, Lasley BL, Brenner RM, Giudice LC et al (2005) Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic acid in the human and rhesus macaque endometrium. J Clin Endocrinol Metab 90(3):1783–1790

    Article  CAS  PubMed  Google Scholar 

  12. Swiercz JM, Worzfeld T, Offermanns S (2008) ErbB-2 and met reciprocally regulate cellular signaling via Plexin-B1. J Biol Chem 283(4):1893–1901

    Article  CAS  PubMed  Google Scholar 

  13. Toyofuku T, Zhang H, Kumanogoh A, Takegahara N, Suto F, Kamei J et al (2004) Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev 18(4):435–447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E et al (2016) Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy. Expert Rev Mol Med 7(18):e18

    Article  Google Scholar 

  15. Zhou Y, Gunput RA, Pasterkamp RJ (2008) Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33(4):161–170

    Article  CAS  PubMed  Google Scholar 

  16. Chadborn NH, Ahmed AI, Holt MR, Prinjha R, Dunn GA, Jones GE et al (2006) PTEN couples Sema3A signalling to growth cone collapse. J Cell Sci 119(Pt 5):951–957

    Article  CAS  PubMed  Google Scholar 

  17. Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R et al (2005) Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 104(2):427–438

    Article  CAS  PubMed  Google Scholar 

  18. Fan F, Wey JS, McCarty MF, Belcheva A, Liu W, Bauer TW et al (2005) Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24(16):2647–2653

    Article  CAS  PubMed  Google Scholar 

  19. Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W et al (2006) Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66(1):46–51

    Article  CAS  PubMed  Google Scholar 

  20. Kruger RP, Aurandt J, Guan KL (2005) Semaphorins command cells to move. Nat Rev Mol Cell Biol 6(10):789–800

    Article  CAS  PubMed  Google Scholar 

  21. Xiang RH, Hensel CH, Garcia DK, Carlson HC, Kok K, Daly MC et al (1996) Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 32(1):39–48

    Article  CAS  PubMed  Google Scholar 

  22. Roche J, Boldog F, Robinson M, Robinson L, Varella-Garcia M, Swanton M et al (1996) Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12(6):1289–1297

    CAS  PubMed  Google Scholar 

  23. Tse C, Xiang RH, Bracht T, Naylor SL (2002) Human semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 62(2):542–546

    CAS  PubMed  Google Scholar 

  24. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL (2002) Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 62(9):2637–2643

    CAS  PubMed  Google Scholar 

  25. Shahi P, Wang CY, Chou J, Hagerling C, Veloso HG, Ruderisch A et al (2017) GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis. Oncogene 36(40):5567–5575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Castro-Rivera E, Ran S, Thorpe P, Minna JD (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 101(31):11432–11437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Regano D, Visintin A, Clapero F, Bussolino F, Valdembri D, Maione F et al (2017) Sema3F (semaphorin 3F) selectively drives an extraembryonic proangiogenic program. Arterioscler Thromb Vasc Biol 37(9):1710–1721. https://doi.org/10.1161/ATVBAHA.117.308226 (Epub 2017 Jul 20)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC et al (2004) Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Investig 114(9):1260–1271

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bielenberg DR, Klagsbrun M (2007) Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26(3–4):421–431

    Article  CAS  PubMed  Google Scholar 

  30. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al (2003) Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63(17):5230–5233

    CAS  PubMed  Google Scholar 

  31. Huang C, Wang Y, Huang JH, Liu W (2017) Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice. BMC Pharmacol Toxicol 18(1):55

    Article  PubMed  PubMed Central  Google Scholar 

  32. Herman JG, Meadows GG (2007) Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol 30(5):1231–1238

    CAS  PubMed  Google Scholar 

  33. Muller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U et al (2007) Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121(11):2421–2433

    Article  PubMed  Google Scholar 

  34. Liang Y, Wang W, Huang J, Tan H, Liu T, Shang C et al (2015) Potential role of semaphorin 3A and its receptors in regulating aberrant sympathetic innervation in peritoneal and deep infiltrating endometriosis. PLoS ONE 10(12):e0146027

    Article  PubMed  PubMed Central  Google Scholar 

  35. Evanno E, Godet J, Piccirilli N, Guilhot J, Milin S, Gombert JM et al (2017) Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to mesenchymal transition in lung cancer. Clin Epigenetics 8(9):80

    Article  Google Scholar 

  36. Paullin T, Powell C, Menzie C, Hill R, Cheng F, Martyniuk CJ, Westerheide SD (2017) Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses. PLoS ONE 12(8):e0182930

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wang Z, Ding M, Qian N, Song B, Yu J, Tang J, Wang J (2017) Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer. World J Surg Oncol 15(1):67

    Article  PubMed  PubMed Central  Google Scholar 

  38. Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ et al (2009) Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 15(22):6763–6770

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Gustavo Dias Ferreira was scholarship recipient from CAPES—Process Number 18471-12-9.

Author information

Authors and Affiliations

  1. Department of Physiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil

    Gustavo Dias Ferreira & Edison Capp

  2. Department of Physiology and Pharmacology, Federal University of Pelotas, Campus Universitário Capão do Leão, s/n, Pelotas, RS, 96010-900, Brazil

    Gustavo Dias Ferreira

  3. Department of Gynecological Endocrinology and Reproductive Medicine, Heidelberg University, Heidelberg, Germany

    Gustavo Dias Ferreira, Edison Capp, Julia Jauckus, Thomas Strowitzki & Ariane Germeyer

Authors
  1. Gustavo Dias Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edison Capp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julia Jauckus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Strowitzki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ariane Germeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GDF project development, data management, data analysis, and manuscript writing. EC and AG project development, data analysis, and manuscript editing. JJ project development and data management. TS project development, data collection, and manuscript editing.

Corresponding author

Correspondence to Gustavo Dias Ferreira.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This project was approved by the Ethics Committee of the Medical Faculty of the Heidelberg University (Number 239-05).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferreira, G.D., Capp, E., Jauckus, J. et al. Expression of semaphorin class 3 is higher in the proliferative phase on the human endometrium. Arch Gynecol Obstet 297, 1175–1179 (2018). https://doi.org/10.1007/s00404-018-4719-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-018-4719-3

Keywords

Search

Navigation